Esketamine may be suitable for adults diagnosed with treatment-resistant depression.
Every patient undergoes a comprehensive consultant-led psychiatric assessment to confirm diagnosis and determine suitability. We do not offer “quick fixes.” We offer careful, evidence-based treatment pathways tailored to the individual.
Our consultant psychiatrists will guide you through:
Only once suitability is confirmed will treatment begin.
Esketamine is administered intranasally using a nasal spray device.
However, unlike standard medications, it is never taken at home.
Each session is delivered exclusively within our clinic under the supervision of trained clinicians. During treatment:
This structured protocol ensures safety, comfort, and optimal monitoring.
Treatment typically follows an induction phase over two months:
Following this phase, some patients may move to a maintenance schedule, with sessions gradually reduced depending on clinical response.
Regular psychiatric review is essential to ensure sustained improvement and long-term remission.
Quick response — Confidential support — Begin your recovery journey.